Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

Technology Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > Podcast
View:
Post by Year3000 on Dec 22, 2023 12:55pm

Podcast

I found this podcast with Lee Buckler which Google says was posted 8 hours ago... 
It says results from studies are coming out this quarter. 

not sure when he was interviewed for this. 

anyone who fancies a listen here is the link: 
https://reachmd.com/programs/primary-care-today/hair-tendons-skin-oh-my-biotechs-quest-tissue-regeneration/8549/

let me know your thoughts

Comment by Ingiboy on Dec 22, 2023 1:53pm
This interview datges back pre Andrew Schutte becoming the CEO.   I am still puzzled why Lee Buckler is a Director of the company.  From what I gather he was not present at the last AGM and non of his tweets make any reference to Replicel.  
Replicel Life Sciences Inc